Related Experiment Video
Updated: May 19, 2026
06:09
Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
GAB2 induces tumor angiogenesis in NRAS-driven melanoma
Oncogene
|August 29, 2012
Summary
GAB2 protein promotes NRAS-driven melanoma growth and metastasis by enhancing cell survival and triggering tumor angiogenesis. Targeting GAB2 may offer new therapeutic strategies for melanoma.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- GAB2 is a scaffold protein implicated in various signaling pathways.
- GAB2 is overexpressed in multiple human cancers, including melanoma.
- Its specific role in NRAS-driven melanoma remains largely undefined.
Purpose of the Study:
- To investigate the role of GAB2 in NRAS-driven melanoma.
- To elucidate the mechanisms by which GAB2 contributes to melanoma progression.
- To establish the link between GAB2 and tumor angiogenesis.
Main Methods:
- Analysis of GAB2 and NRAS co-expression in melanoma cell lines and tumor samples.
- Assessment of anchorage-independent growth and cell survival assays.
- In vivo tumorigenesis studies in mice.
- Evaluation of angiogenesis markers (CD34, VEGFR2, HIF-1α, VEGF).
- Treatment with MEK inhibitor PD325901.
Main Results:
- GAB2 is co-expressed with mutant NRAS in melanoma and correlates with metastatic potential.
- GAB2/NRAS co-expression enhances anchorage-independent growth and cell survival via BCL-2 family proteins.
- GAB2 promotes in vivo tumorigenesis, increases vessel density, and upregulates HIF-1α and VEGF, facilitating an angiogenic switch.
- MEK inhibition significantly suppresses the angiogenic response.
- GAB2/NRAS signaling axis is non-linear and non-redundant.
Conclusions:
- GAB2 is a novel regulator of tumor angiogenesis in NRAS-driven melanoma.
- GAB2 collaborates with NRAS to promote melanoma aggressiveness through enhanced survival and angiogenesis.
- GAB2 regulates HIF-1α and VEGF expression via the RAS-RAF-MEK-ERK pathway.
- GAB2 represents a potential therapeutic target for NRAS-driven melanoma.
Related Concept Videos
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:10Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:24Small GTPases - Ras and Rho
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
02:38The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...
01:07MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...